Pathology Dataset Executive Summary
High-Fidelity Clinical Metadata for Advanced Model Training
Comprehensive Metadata Summary: Strategic Health Dataset
Our dataset of 37,000+ clinical records offers a multidimensional view of patient health, combining standard screenings with high-value metabolic and hormonal markers.
1. High-Value Clinical Domains
Unlike standard datasets, our records provide a 360-degree health profile for each patient ID:
Metabolic & Insulin Health: Includes HOMA-IR (Insulin Resistance), HbA1c, and Fasting Insulin. This is a "Gold Standard" for AI models predicting Type 2 Diabetes years before onset.
Hormonal & Special Markers: Detailed data on Testosterone (Total), PSA (Prostate Health), and Thyroid (TSH) profiles.
Organ Vitality Panels: Full Liver (LFT) and Kidney (RFT/eGFR) profiles, including specific markers like GGT and Urine Albumin-Creatinine Ratio (uACR) for early disease detection.
Lipid & Inflammatory Markers: Comprehensive Lipid panels (TC, LDL, HDL, TG, VLDL) paired with hs-CRP to assess cardiovascular inflammation risk.
Micronutrient Mapping: Extensive data on Vitamin D (25-OH), Vitamin B12, and Iron Studies (Ferritin/TIBC).
2. Data Integrity & Technical Quality
Accuracy: All samples are processed in ISO 15189:2012 Certified laboratories.
Methodology: Utilizing advanced Photometry and automated Hematology Analyzers, ensuring high-fidelity numerical data.
Demographic Diversity: Our dataset covers a broad spectrum of nationalities, including British/European, Indian, Bangladeshi, and Omani populations, ensuring AI models are trained without ethnic bias.
| Patient ID | Age/Sex | Nationality | Key Findings / Clinical Highlights | Data Points Included |
|---|---|---|---|---|
| PID_0009461 | 33 / M | Arab | Diabetes & Liver Stress: High HbA1c (7.3%) and Elevated Fasting Glucose (7.7). ALT (85.2) is significantly above range. | Fasting Glucose, HbA1c, LFT, Lipid, Renal, CBC |
| PID_0009534 | 51 / M | Indian | Dyslipidemia: Low HDL (0.8) and High Triglycerides (1.9). Microcytic RBC indices observed in CBC. | Fasting Glucose, Lipid Profile, LFT, CBC, Renal |
| PID_0010085 | 38 / M | Bangladeshi | Normal Baseline: All metabolic and hematological markers within reference limits. Blood Group: B+ | LFT, Lipid, Renal, CBC, ESR, Blood Group, Urinalysis |
| PID_0010086 | 21 / M | Bangladeshi | Healthy Young Adult Profile: Optimal Glucose (4.9) and Renal functions. Comprehensive liver enzymes. | Fasting Glucose, LFT, Lipid Profile, Renal Profile |
| PID_00078 | 50 / M | Indian | Gout Risk & Hematuria: Very High Uric Acid (529). Urine shows Blood (++) and 28-30 RBCs. High Triglycerides. | CBC, Uric Acid, Lipid Profile, Urinalysis |
| Patient ID | Age/Sex | Nationality | Key Findings / Clinical Highlights | Data Points Included |
|---|---|---|---|---|
| PID_00001 | 47 / M | BRITISH | Metabolic Syndrome Risk: High HOMA-IR (2.4) indicating early insulin resistance. Dyslipidemia (High LDL & TG). Liver stress (Elevated ALT/GGT). Vitamin D insufficiency. | HOMA-IR, HbA1c, PSA, Testosterone, Vitamins (D, B12), LFT, Lipid, Renal, hsCRP |
| PID_0009461 | 33 / M | Arab | Diabetes & Liver Stress: High HbA1c (7.3%) and Elevated Fasting Glucose (7.7). ALT (85.2) is significantly above range. | Fasting Glucose, HbA1c, LFT, Lipid, Renal, CBC |
| PID_0009534 | 51 / M | INDIAN | Dyslipidemia: Low HDL (0.8) and High Triglycerides (1.9). Microcytic RBC indices observed in CBC. | Fasting Glucose, Lipid Profile, LFT, CBC, Renal |
| PID_0010085 | 38 / M | BANGLADESHI | Normal Baseline: All metabolic and hematological markers within reference limits. Blood Group: B+ | LFT, Lipid, Renal, CBC, ESR, Blood Group, Urinalysis |
| PID_0010086 | 21 / M | BANGLADESHI | Healthy Young Adult Profile: Optimal Glucose (4.9) and Renal functions. Comprehensive liver enzymes. | Fasting Glucose, LFT, Lipid Profile, Renal Profile |
| Profile Type | Key Clinical Findings in Dataset | AI/Research Use Case |
|---|---|---|
| Metabolic Risk | Insulin Resistance (HOMA-IR > 1.9), High HbA1c | Early Diabetes Prediction |
| Cardiovascular | High LDL/TG Ratio, Low HDL, Elevated hs-CRP | Heart Disease Risk Modeling |
| Hepatic Stress | Elevated ALT & GGT linked with Metabolic markers | NAFLD/Fatty Liver Analytics |
| Baseline Normal | Healthy reference ranges across all 10+ panels | Control Group Training |